When Your Product Outgrows Your Patent: The Provisional Window and Continuation Practice

When Your Product Outgrows Your Patent: Jeff Schell, patent lawyer, on the 12-month provisional window and continuation practice
Watch on YouTube: AI Can Copy Your Product. Can Patents Protect Your Business? · starts at the after-the-provisional segment (48:05); continuation practice is at 64:00

A provisional patent application gives you 12 months of patent pending status, and most founders keep developing their product during those 12 months.

That second part is where I see trouble. In a long conversation with Majid Boroujerdi (the full session is the video above, from my Schell IP channel), he asked me two questions that belong together: what should a founder work through after a provisional is filed, and how should IP strategy change as the product and business model change? My answer to both is the same problem. Founders get out over their skis with product development, and their patent coverage doesn’t keep up.

I covered the disclosure and ownership mistakes from the same conversation in Two Patent Mistakes Founders Make. This post picks up after the first filing.

What the 12-month provisional window is for

A provisional is a placeholder application. Once it’s filed, you can go back to that filing date and say you have patent pending on whatever we put into the provisional. That last phrase matters. The provisional covers what it describes, not every improvement you make afterward.

The USPTO is direct about the clock. A provisional has a pendency of 12 months from its filing date, that period cannot be extended, and you need to file a corresponding nonprovisional application within those 12 months to benefit from the earlier date. Provisionals also aren’t examined, so nobody at the patent office is going to tell you your product has drifted away from what you filed.

In my experience, when people file a provisional, it’s usually because they’re still developing some aspect of the invention, or a complementary invention that goes with it. That’s normal. It’s also why the 12 months shouldn’t be dead time.

What I work through before the next filing

Before the nonprovisional goes in, I want to understand how the research and development has progressed while the provisional was pending. Specifically:

  • What changed about the product you’re trying to launch, or the invention you’re trying to commercialize, since the provisional’s filing date.
  • Which of those changes the provisional already describes and which ones are new.
  • A strategy to cover the new parts, which often includes a patentability search, especially on the aspects of the invention that came out of that 12-month period.

This is easier when the provisional was drafted with the future in mind. As I explained in First Patent for Startups: File Before You Pitch, you can describe an invention one narrow way, or you can describe it several ways while forecasting where it’s likely to go. The second approach gives you more of a halo and makes it harder for competitors to design around you later.

One option the rules allow: a nonprovisional can claim the benefit of more than one earlier provisional, as long as each one is still inside its own window. The USPTO covers how benefit claims to provisionals work in MPEP 211. Whether that’s the right move for a given product is a strategy question, not a default.

When your patents stop matching your product

Patents add value to a company. They can materially affect valuation and investment decisions. But if it becomes clear that your patents don’t encompass what you’re actually doing, your patents can also be worthless.

That usually comes out at the worst time, when an investor or a buyer looks at your claims next to your current product. It’s one reason an early-stage founder needs patent counsel who knows how the M&A process and the investment process work, and not just how to get an application allowed. I go into how buyers and investors weigh patents in Startup Patent Strategy: How Strategic Claims Raise Your Exit Multiple and Patents for Startups: Why Your Exit Depends on IP.

The fix is to iterate your portfolio, and broaden it where it makes sense, so it tracks your R&D instead of lagging it.

Continuation practice: keeping a patent family open

The main tool for that is continuation practice. Here’s the example I gave on the show. Say your parent patent application describes 75% of the new product you’re launching. We may need another filing in that same patent family to capture the other 25% of the innovation. We can do that later and keep the priority date for what the parent already described, so you don’t lose the ability to capture that 75%.

Two rules shape how this works, and both are worth knowing:

  • The parent has to still be pending. Under 35 U.S.C. § 120, a later application gets the earlier filing date for an invention the earlier application disclosed, but only if it’s filed before the earlier application is patented or abandoned. If every application in the family has issued or been abandoned, that door is closed.
  • The earlier date covers what the earlier application disclosed. The USPTO describes a continuation-in-part as an application that repeats some or all of the prior application and adds matter that wasn’t disclosed there (MPEP 201). Because § 120 ties the earlier date to what was disclosed, genuinely new material is judged from the later date. That’s another reason a thorough early description pays off.

Continuations aren’t free, and they shouldn’t be filed by reflex. I’d tie them to your product roadmap, which we cover in Patent Portfolio Strategy Starts with the Product Roadmap. For how continuations also help a portfolio adjust to USPTO policy swings, see How USPTO Policy Changes Affect Patent Value and Strategy.

Founder takeaway

Your patent should describe the product you sell, not the product you pitched a year ago. A short checklist:

  1. Put the provisional’s 12-month date on the calendar. It can’t be extended.
  2. Meet with counsel well before that date and list everything that changed in the product since you filed.
  3. Search the new aspects. A patentability search on what came out of the last 12 months tells you what’s worth claiming.
  4. Keep at least one application pending in the family that covers your core product while the product is still evolving, so continuation options stay open.
  5. Compare your claims to your current product before you raise or sell. If they don’t line up, it’s far better to find out before an investor or buyer does.

FAQ

What happens if I miss the 12-month provisional deadline?

The provisional’s 12-month pendency can’t be extended. To benefit from the provisional’s filing date, you need to file a corresponding nonprovisional application within those 12 months.

Does my provisional cover changes I make to the product after filing?

Not automatically. Patent pending covers what you put into the provisional. Changes made after filing need to be reviewed, often with a patentability search, and covered in a later filing if they’re worth protecting.

What is a continuation patent application?

It’s a later application in the same patent family that claims the benefit of an earlier application’s filing date for what the earlier application disclosed. Under 35 U.S.C. § 120, it has to be filed while the earlier application is still pending.

Why would a patent be worth little at an exit?

If it becomes clear that the patents don’t encompass what the company is actually doing, they can be close to worthless in a fundraising or acquisition conversation, even if they were well drafted for the original product.

Line up your next filing with your product

If you filed a provisional and the product has moved since, now is the time to plan the next filing. Schell IP works with startup founders and product teams, and you can find more guides in our Patent Resource Library. Book a free consultation or call (720) 419-1296.

Book a Free Consultation

author avatar
Jeff Schell Patent Lawyer, Venture Capitalist
Jeff Schell is a leading Denver patent lawyer and Boulder patent lawyer, known for founding Rocky Mountain Patent and merging it with a top firm in 2018. As CEO of TranS1, he led the company to a successful exit and numerous awards. Schell also co-founded Proov, an award-winning women’s health brand. With expertise in patent law, technology, and entrepreneurship, he now leads Schell IP and Nova Launch Partners. Recognized as one of Colorado’s “Most Influential Young Professionals,” Schell is also a mentor for TechStars and Boomtown accelerators and President of TiE Denver.

Book a free patent consultation.

Learn how the entrepreneurial experience and legal expertise of patent lawyer Jeff Schell provides highly unique advantages for our clients.